医学
闭塞
改良兰金量表
外科
背景(考古学)
动脉瘤
支架
放射科
内科学
缺血
生物
古生物学
缺血性中风
作者
Mohamed M. Salem,Ahmed Helal,Avi A. Gajjar,Georgios S. Sioutas,Kareem El Naamani,Daniel M. Heiferman,Iván Lylyk,Alex Levine,Leonardo Renieri,André Monteiro,Mira Salih,Rawad Abbas,Ahmed M. Abdelsalam,Sohum Desai,Hamidreza Saber,Joshua S. Catapano,Nicholas Borg,Giuseppe Lanzino,Waleed Brinjikji,Omar Tanweer
标识
DOI:10.1136/jnis-2024-022422
摘要
Background Flow-diverter stents (FDS) have become the standard of care for a wide range of intracranial aneurysms, but their efficacy/safety in the context of recurrent/recanalized aneurysms following stent-assisted coiling (SAC) is not well established. We evaluate the outcomes of FDS retreatment in a large multicenter cohort. Methods We retrospectively analyzed data from 118 patients across 22 institutions who underwent FDS retreatment for recurrent/persistent aneurysms after SAC (2008–22). The primary outcome was angiographic occlusion status at last follow-up, categorized as complete (100%), near-complete (90–99%), or incomplete (<90%) occlusion. Secondary outcomes included procedural complications and clinical outcomes measured by the modified Rankin Scale (mRS). Results A total of 118 patients (median age 57, 74.6% female) with median follow-up of 15.3 months were identified. Complete occlusion was achieved in 62.5% and near-complete occlusion in 25%. FDS deployment within the pre-existing stent was successful in 98.3% of cases. Major complications occurred in 3.4% of cases, including postoperative aneurysmal rupture with resultant mortality (1.6%) and thromboembolic events with long-term disability (1.6%). Favorable clinical outcomes (mRS 0–2) were observed in 95.1% of patients. Wider aneurysm neck diameter was a significant predictor of incomplete occlusion (adjusted OR (aOR) 1.23 per mm, P=0.044), with male sex trending towards association with non-occlusion (aOR 3.2, P=0.07), while baseline hypertension was associated with complete occlusion (aOR 0.32, P=0.048). Conclusions FDS treatment for recurrent/residual aneurysms after SAC represents a viable treatment option for these challenging cases with acceptable safety and reasonable occlusion rates, although lower than de novo FDS occlusion rates.
科研通智能强力驱动
Strongly Powered by AbleSci AI